Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17β-estradiol

Environmental Health Perspectives

Volumn 117, Issue 5, 2009, Pages 778-783

  Alyea, Rebecca A ^a   Watson, Cheryl S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Dopamine efflux; Low concentrations; Nongenomic; Xenoestrogens

Indexed keywords

2,4 DICHLORODIPHENYLETHYLENE; 4,4' ISOPROPYLIDENEDIPHENOL; DIELDRIN; DOPAMINE 3 RECEPTOR; DOPAMINE TRANSPORTER; ENDOSULFAN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHYLENE; G PROTEIN COUPLED RECEPTOR; NONYLPHENOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY TEST; DOPAMINE UPTAKE; IMMUNOASSAY; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM;

ANIMALS; BIOLOGICAL TRANSPORT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; PC12 CELLS; PHENOLS; RATS; WATER POLLUTANTS, CHEMICAL;

RATTUS;

EID: 66349094214     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800026     Document Type: Article

References (50)

1. Agency for Toxic Substances and Disease Registry. 2002 Toxicological Profile for Aldrin and Dieldrin. Atlanta: GA: Agency for Toxic Substances and Disease Registry. Available: http://www.atsdr.cdc.gov/ toxprofiles/tp1.html [accessed 1 April 2009].
2. Alyea RA, Laurence SE, Kim SH, Katzenellenbogen BS, Katzenellenbogen JA, Watson CS. 2008. The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neurochem 106:1525-1533.
3. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ, McLachlan JA. 1996. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272:1489-1492.
4. Bemis JC, Seegal RF. 2004. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content. Toxicol Sci 80:288-295.
5. Bornman MS, Pretorius E, Marx J, Smit E, van der Merwe CF. 2007. Ultrastructural effects of DDT, DDD, and DDE on neural cells of the chicken embryo model. Environ Toxicol 22:328-336.
6. Bulayeva NN, Watson CS. 2004. Xenoestrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Environ Health Perspect 112:1481-1487.
7. Campbell CH, Watson CS. 2001. A comparison of membrane vs. intracellular estrogen receptor-alpha in GH(3)/B6 pituitary tumor cells using a quantitative plate immunoassay. Steroids 66:727-736.
8. Colborn T. 2004. Neurodevelopment and endocrine disruption. Environ Health Perspect 112:944-949.
9. Evans SM. 2007. The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp Clin Psychopharmacol 15:418-426.
10. Fail PA, Chapin RE, Price CJ, Heindel JJ. 1998. General, reproductive, developmental, and endocrine toxicity of boronated compounds. Reprod Toxicol 12:1-18.
11. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, et al. 2001. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 14:280-294.
12. Fischer JF, Cho AK. 1979. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209.
13. Gruber CJ, Gruber DM, Gruber IM, Wieser F, Huber JC. 2004. Anatomy of the estrogen response element. Trends Endocrinol Metab 15:73-78.
14. Hatcher JM, Delea KC, Richardson JR, Pennell KD, Miller GW. 2008. Disruption of dopamine transport by DDT and its metabolites. Neurotoxicology 29:682-690.
15. Hotchkiss AK, Rider CV, Blystone CR, Wilson VS, Hartig PC, Ankley GT, et al. 2008. Fifteen years after "Wingspread" - environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol Sci 105:235-259.
16. Janowsky A, Neve K, Eshleman AJ. 1998. Uptake and release of neurotransmitters. Curr Protocols Neurosci (suppl 2): 7.9.1-7.9.22. Available: http://mrw.interscience.wiley. com/emrw/9780471142300/cp/cpns/ article/ns0709/current/pdf [accessed 1 April 2009].
17. Kitazawa M, Anantharam V, Kanthasamy AG. 2001. Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic Biol Med 31:1473-1485.
18. Koldzic-Zivanovic N, Seitz PK, Watson CS, Cunningham KA, Thomas ML. 2004. Intracellular signaling involved in estrogen regulation of serotonin reuptake. Mol Cell Endocrinol 226:33-42.
19. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. 1993. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132:2279-2286.
20. Kwon JH, Katz LE, Liljestrand HM. 2007. Modeling binding equilibrium in a competitive estrogen receptor binding assay. Chemosphere 69:1025-1031.
21. Lakshmana MK, Raju TR. 1994. Endosulfan induces small but significant changes in the levels of noradrenaline, dopamine and serotonin in the developing rat brain and deficits in the operant learning performance. Toxicology 91:139-150.
22. McArthur S, Murray HE, Dhankot A, Dexter DT, Gillies GE. 2007. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. J Neurochem 100:678-692.
23. McEwen BS, Alves SE. 1999. Estrogen actions in the central nervous system 1. Endocr Rev 20:279-307.
24. McKinlay R, Plant JA, Bell JN, Voulvoulis N. 2008. Calculating human exposure to endocrine disrupting pesticides via agricultural and non-agricultural exposure routes. Sci Total Environ 398:1-12.
25. Milligan SR, Balasubramanian AV, Kalita JC. 1998. Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. Environ Health Perspect 106:23-26.
26. Miyatake M, Miyagawa K, Mizuo K, Narita M, Suzuki T. 2006. Dynamic changes in dopaminergic neurotransmission induced by a low concentration of bisphenol-A in neurones and astrocytes. J Neuroendocrinol 18:434-444.
27. Mozley LH, Gur RC, Mozley PD, Gur RE. 2001. Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry 158:1492-1499.
28. Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, et al. 2006. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59:966-974.
29. Naqvi SM, Vaishnavi C. 1993. Bioaccumulative potential and toxicity of endosulfan insecticide to non-target animals. Comp Biochem Physiol C 105:347-361.
30. Nikov GN, Hopkins NE, Boue S, Alworth WL. 2000. Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environ Health Perspect 108:867-872.
31. Prasad KN, Cole WC, Kumar B. 1999. Multiple antioxidants in the prevention and treatment of Parkinson's disease. J Am Coll Nutr 18:413-423.
32. Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW. 2006. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. FASEB J 20:1695-1697.
33. Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG. 2003. Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in indoor air and dust. Environ Sci Technol 37:4543-4553.
34. Sava V, Velasquez A, Song S, Sanchez-Ramos J. 2007. Dieldrin elicits a widespread DNA repair and antioxidative response in mouse brain. J Biochem Mol Toxicol 21:125-135.
35. Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S, et al. 2003. Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine d1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience 117:639-644.
36. Torres GE, Gainetdinov RR, Caron MG. 2003. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13-25.
37. Toyohira Y, Utsunomiya K, Ueno S, Minami K, Uezono Y, Yoshimura R, et al. 2003. Inhibition of the norepinephrine transporter function in cultured bovine adrenal medullary cells by bisphenol A. Biochem Pharmacol 65:2049-2054.
38. Volz TJ, Fleckenstein AE, Hanson GR. 2007. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 102(suppl 1):44-48.
39. vom Saal FS, Hughes C. 2005. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113:926-933.
40. vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, et al. 1997. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 94:2056-2061.
41. Watson CS, Alyea RA, Hawkins BE, Thomas ML, Cunningham KA, Jakubas AA. 2006. Estradiol effects on the dopamine transporter - protein levels, subcellular location, and function. J Mol Signal 1:5; doi:10.1186/ 1750-2187-1-5 [Online 5 December 2006].
42. Watson CS, Alyea RA, Jeng YJ, Kochukov MY. 2007a. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol 274:1-7.
43. Watson CS, Bulayeva NN, Wozniak AL, Alyea RA. 2007b. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 72:124-134.
44. Watson CS, Bulayeva NN, Wozniak AL, Finnerty CC. 2005. Signaling from the membrane via membrane estrogen receptor-α: estrogens, xenoestrogens, and phytoestrogens. Steroids 70:364-371.
45. Watson CS, Gametchu B. 1999. Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 220:9-19.
46. Watson CS, Jeng YJ, Kochukov MY. 2008. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J 22:3328-3336.
47. White TL, Justice AJ, de Wit H. 2002. Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73:729-741.
48. 2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 113:431-439.
49. Yang L, Lin L, Weng S, Feng Z, Luan T. 2008. Sexually disrupting effects of nonylphenol and diethylstilbestrol on male silver carp (Carassius auratus) in aquatic microcosms. Ecotoxicol Environ Saf 71:400-411.
50. Yoneda T, Hiroi T, Osada M, Asada A, Funae Y. 2003. Non-genomic modulation of dopamine release by bisphenol-A in PC12 cells. J Neurochem 87:1499-1508.